Psychedelic Stocks,Shroom News MindMed Collaborators to Present Clinical Trial Results for LCD in Anxiety Disorder at PSYCH Symposium By Dennis Mutua April 19, 2022 Biopharmaceutical company developing psychedelics-inspired medicines and therapies to address addiction and brain health disorders MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced that its collaborators at University Hospital Bas...
Featured,Spotlight Stock Delic Labs Granted Permission to Study Psychedelics Compounds By Dennis Mutua April 18, 2022 Licensed cannabis and psilocybin research company focused on advanced research, testing and analysis for the psychedelic-wellness industry Delics Labs has been granted a section 56 exemption from Health Canada giving permission to...
Featured,Trends & Articles Cannsun Granted Regulatory Approval to Conduct Phase 2 Psilocybin Trials in Africa By Dennis Mutua April 15, 2022 Bio-pharmaceutical company focusing on developing and commercializing new medicines to optimize human health Cannsun Group PLC announced having been granted regulatory approval by the South African Health Products Regulatory Autho...
Psychedelic Stocks Oregon Psilocybin: Ready to Launch (Webinar Replay) By Dennis Mutua April 14, 2022 For anyone who was unable to join our April 7th webinar, Oregon Psilocybin: Ready to Launch, we’ve got you covered! Below, please find the full presentation below for your viewing pleasure. Stay up to date by subscribing to the ...
Psychedelic Stocks,Shroom News Filament Health Granted Patent for Extraction and Standardization of Natural Psilocybin By Dennis Mutua April 14, 2022 Clinical stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FLHLF) has received a patent allowing it to extract and standardize natural psilo...
Psychedelic Stocks Microdosing at Work By Dennis Mutua April 13, 2022 This article was originally published on Bill of Health, the blog of Petrie-Flom Center at Harvard Law School, as part of a digital symposium, A Macro View of Microdosing. In light of the widespread cultural and business cultu...
Featured,Spotlight Stock,Trends & Articles Numinus Inks Deal to Acquire Novamind in What Will Become Biggest Psychedelics Merger By Dennis Mutua April 13, 2022 Mental health and wellness company combining the practices of administering psychedelics medicine with holistic integrated psychotherapy Numinus Wellness Inc. (TSX: NUMI) (OTCMKTS: NUMIF) has signed a deal agreeing to acquire fell...
Psychedelic Stocks Oregon Psilocybin Draft Rules: Training By Dennis Mutua April 12, 2022 On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin services. These rules focus on psilocybin products, testing, and training programs. There will ...